Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, today closed its initial public offering (“IPO”) of 24,000,000 common shares at a price to the public of $16.00 per share. The IPO consists of 9,000,000 new common shares issued and sold by Titan America and 15,000,000 existing common shares sold by Titan Cement International SA. Titan America’s common shares began trading on the New York Stock Exchange under the ticker symbol “TTAM” on February 7, 2025.
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
